Imran Khan

NPI: 1992908123
Total Payments
$1,367
2021 Payments
$123.77
Companies
9
Transactions
38
Medicare Patients
2,325
Medicare Billing
$291,940

Payment Breakdown by Category

Food & Beverage$1,367 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,367 38 100.0%

Top Paying Companies

Company Total Records Latest Year
BOSTON SCIENTIFIC CORPORATION $373.09 3 $0 (2021)
Merck Sharp & Dohme Corporation $299.82 6 $0 (2019)
PFIZER INC. $237.30 8 $0 (2019)
Janssen Pharmaceuticals, Inc $174.85 6 $0 (2020)
E.R. Squibb & Sons, L.L.C. $169.00 9 $0 (2019)
Abbott Laboratories $50.94 3 $0 (2017)
Melinta Therapeutics, LLC $28.12 1 $0 (2020)
Nabriva Therapeutics, plc $22.76 1 $0 (2020)
Novartis Pharmaceuticals Corporation $10.71 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2021 $123.77 1 BOSTON SCIENTIFIC CORPORATION ($123.77)
2020 $324.92 5 Boston Scientific Corporation ($249.32)
2019 $364.21 8 Merck Sharp & Dohme Corporation ($280.87)
2018 $127.08 7 Janssen Pharmaceuticals, Inc ($59.46)
2017 $426.61 17 PFIZER INC. ($170.60)

All Payment Transactions

38 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
07/20/2021 BOSTON SCIENTIFIC CORPORATION RESONATE (Device) Food and Beverage Cash or cash equivalent $123.77 General
Category: RESONATE
11/19/2020 Boston Scientific Corporation LUX-DX (Device) Food and Beverage In-kind items and services $127.39 General
Category: THERAPIES
09/10/2020 Boston Scientific Corporation SQ-RX PULSE GENERATOR (Device) Food and Beverage In-kind items and services $121.93 General
Category: TACHY
03/04/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $24.72 General
Category: Cardiovascular & Metabolism
02/19/2020 Nabriva Therapeutics, plc Xenleta (Drug) Food and Beverage In-kind items and services $22.76 General
Category: Antibiotic
01/21/2020 Melinta Therapeutics, LLC Orbactiv (Drug), Vabomere, Baxdela Food and Beverage In-kind items and services $28.12 General
Category: ANTIBIOTICS
12/11/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $35.66 General
Category: Cardiovascular & Metabolism
11/26/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $33.15 General
11/21/2019 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $119.45 General
Category: INFECTIOUS DISEASE
11/12/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $23.06 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/10/2019 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $90.00 General
Category: INFECTIOUS DISEASE
08/20/2019 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $24.62 General
Category: Cardiovascular
02/21/2019 Merck Sharp & Dohme Corporation DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $18.50 General
Category: INFECTIOUS DISEASE
02/13/2019 Merck Sharp & Dohme Corporation DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $19.77 General
Category: INFECTIOUS DISEASE
11/09/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $36.83 General
Category: Cardiovascular & Metabolism
09/26/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $13.09 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/26/2018 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $10.84 General
Category: Cardiovascular
04/12/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $15.49 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
04/12/2018 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $13.14 General
Category: Cardiovascular
02/21/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.63 General
Category: Cardiovascular & Metabolism
02/14/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $15.06 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/17/2017 Abbott Laboratories CardioMEMS HF System (Device) Food and Beverage In-kind items and services $22.22 General
Category: Cardiac Arrhythmias and Heart Failure
10/25/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $31.80 General
Category: Cardiovascular & Metabolism
10/12/2017 Abbott Laboratories CardioMEMS HF System (Device) Food and Beverage In-kind items and services $14.36 General
Category: Cardiac Arrhythmias and Heart Failure
10/12/2017 Abbott Laboratories CardioMEMS HF System (Device) Food and Beverage In-kind items and services $14.36 General
Category: Cardiac Arrhythmias and Heart Failure

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 708 1,331 $193,208 $76,541
2022 10 587 1,176 $208,753 $79,701
2021 8 521 890 $124,146 $68,086
2020 9 509 855 $119,528 $67,612
Total Patients
2,325
Total Services
4,252
Medicare Billing
$291,940
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 250 742 $70,297 $30,079 42.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 256 277 $65,379 $25,863 39.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 86 193 $29,988 $12,024 40.1%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 79 81 $16,650 $5,067 30.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 37 38 $10,894 $3,508 32.2%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 205 751 $113,865 $44,492 39.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 140 146 $32,906 $12,570 38.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 75 75 $21,459 $7,651 35.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 34 52 $11,270 $4,340 38.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 15 17 $7,191 $2,703 37.6%
99217 Hospital observation care on day of discharge Facility 2022 41 42 $6,427 $2,294 35.7%
99219 Initial hospital observation care per day, typically 50 minutes Facility 2022 23 23 $6,414 $2,069 32.3%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 17 17 $3,631 $1,430 39.4%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 21 35 $2,870 $1,137 39.6%
99225 Follow-up observation care per day, typically 25 minutes Facility 2022 16 18 $2,720 $1,014 37.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 183 503 $55,833 $31,019 55.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 145 151 $25,368 $13,843 54.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 39 73 $11,680 $6,406 54.8%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 52 53 $11,236 $5,922 52.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 30 30 $9,360 $5,214 55.7%
99219 Hospital observation care, typically 50 minutes Facility 2021 27 27 $5,616 $2,973 52.9%
99217 Hospital observation care on day of discharge Facility 2021 34 35 $3,955 $2,143 54.2%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 11 18 $1,098 $565.76 51.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 102 245 $39,200 $22,316 56.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 135 309 $34,299 $19,596 57.1%

About Imran Khan

Imran Khan is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992908123.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Imran Khan has received a total of $1,367 in payments from pharmaceutical and medical device companies, with $123.77 received in 2021. These payments were reported across 38 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,367).

As a Medicare-enrolled provider, Khan has provided services to 2,325 Medicare beneficiaries, totaling 4,252 services with total Medicare billing of $291,940. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hospitalist
  • Location Pasadena, CA
  • Active Since 06/06/2007
  • Last Updated 09/09/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1992908123

Products in Payments

  • ELIQUIS (Drug) $339.33
  • ZERBAXA (Drug) $228.40
  • XARELTO (Drug) $174.85
  • LUX-DX (Device) $127.39
  • RESONATE (Device) $123.77
  • SQ-RX PULSE GENERATOR (Device) $121.93
  • OPDIVO (Biological) $66.97
  • CardioMEMS HF System (Device) $50.94
  • DIFICID (Drug) $38.27
  • Orbactiv (Drug) $28.12
  • Xenleta (Drug) $22.76
  • ENTRESTO (Drug) $10.71

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Pasadena